Comparison of standard dose with high dose of methylprednisolone in the management of COVID-19 patients admitted in ICU

Comparison of standard dose with high dose of methylprednisolone in the management of COVID-19 patients admitted in ICU

Context: The pathological progression in severe Coronavirus Disease 2019 (COVID-19) includes an excessive and unregulated pro-inflammatory cytokine storm. Though the efficacy of corticosteroids like methylprednisolone (MPS) in severe COVID-19 is proven now, its dose and duration are not precise. Aim...

Full description

Bibliographic Details
Main Authors: Abhishek Singhai, Parneet Kaur Bhagtana, Neeraj Pawar, G Sai Pavan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
corticosteroid
covid-19
methylprednisolone
respiratory failure
sepsis
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2021;volume=10;issue=11;spage=4066;epage=4071;aulast=Singhai

Internet

http://www.jfmpc.com/article.asp?issn=2249-4863;year=2021;volume=10;issue=11;spage=4066;epage=4071;aulast=Singhai

Similar Items